Molbio Diagnosti vs Tarsons Products Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Molbio Diagnosti currently has the stronger revenue growth signal.
Molbio Diagnosti and Tarsons Products Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Molbio Diagnosti | Tarsons Products Ltd |
|---|---|---|
| Current Price | ₹1,574.4 | ₹331.2 |
| Market Cap | ₹18,143.38 Cr. | ₹1,761.39 Cr. |
| Industry | Healthcare Equipment & Supplies | Healthcare Equipment & Supplies |
| P/E Ratio | 83.57 | 148.76 |
| ROE (%) | 13.84 | 2.44 |
| Debt/Equity | 0.3 | 0.62 |
| Sales Growth 5Y (%) | 0.65 | 13.04 |
| Profit Growth 5Y (%) | — | 72.08 |
| Promoter Holding (%) | 41.29 | 47.3 |
| Revenue Rank | Rank 2 | Rank 3 |
| Margin Rank | Rank 3 | Rank 3 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No |